Other
Drug Facts
The following Structured Product Label (SPL) was submitted to the FDA by Asclemed Usa Inc. for the product Miralax (NDC 76420-489). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding other, active ingredient (in each dose) (bottle only), purpose, active ingredient (in each dose) (packet only), use, allergy alert, otc - do not use, ask a doctor before use if you have, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Drug Facts
Polyethylene Glycol 3350, 17 g (cap filled to line)
Osmotic Laxative
Osmotic Laxative
Polyethylene Glycol 3350, 17 g
Do not use if you are allergic to polyethylene glycol
Do not useif you have kidney disease, except under the advice and supervision of a doctor
Ask a doctor of pharmacist before use if you aretaking a prescription drug
When using this productyou may have loose, watery, more frequent stools
If pregnant or breast-feeding,ask a health professional before use.
Keep out of the reach of children.In case of overdose, get medical help or contact a Poison Control Center right away.
none
1-800-MiraLAX (1-800-647-2529)
* Please review the disclaimer below.